Arcutis Biotherapeutics, Inc. - Common Stock (ARQT)
CUSIP: 03969K108
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,541,881
- Total 13F shares
- 33,776,828
- Share change
- +1,093,678
- Total reported value
- $1,021,408,758
- Price per share
- $30.24
- Number of holders
- 55
- Value change
- +$33,104,690
- Number of buys
- 32
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 03969K108?
CUSIP 03969K108 identifies ARQT - Arcutis Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969K108:
Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
8.6%
|
10,542,790
|
$314,175,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
4.7%
|
5,713,343
|
$170,258,000 | — | 31 Mar 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.8%
|
4,673,850
|
$139,281,000 | — | 31 Mar 2020 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3.2%
|
3,979,292
|
$118,583,000 | — | 31 Mar 2020 | |
| Vivo Capital, LLC |
13F
|
Company |
1.4%
|
1,686,527
|
$50,259,000 | — | 31 Mar 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.95%
|
1,165,184
|
$34,722,000 | — | 31 Mar 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.8%
|
980,614
|
$29,222,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.71%
|
865,309
|
$25,786,000 | — | 31 Mar 2020 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.69%
|
844,680
|
$25,171,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.34%
|
413,771
|
$12,331,000 | — | 31 Mar 2020 | |
| Polar Capital LLP |
13F
|
Company |
0.31%
|
375,000
|
$11,175,000 | — | 31 Mar 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.21%
|
254,439
|
$7,584,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
199,630
|
$5,949,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.14%
|
175,408
|
$5,227,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
167,558
|
$4,993,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
108,459
|
$3,232,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
68,836
|
$2,051,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
60,380
|
$1,799,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
55,565
|
$1,656,000 | — | 31 Mar 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
0.04%
|
50,000
|
$1,490,000 | — | 31 Mar 2020 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.03%
|
41,315
|
$1,231,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
38,896
|
$1,159,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
24,084
|
$718,000 | — | 31 Mar 2020 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.02%
|
22,413
|
$668,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
22,021
|
$657,000 | — | 31 Mar 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
20,474
|
$610,000 | — | 31 Mar 2020 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
19,936
|
$594,000 | — | 31 Mar 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
16,000
|
$477,000 | — | 31 Mar 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
15,811
|
$471,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
11,884
|
$354,000 | — | 31 Mar 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
9,881
|
$294,000 | — | 31 Mar 2020 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.01%
|
7,500
|
$224,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,468
|
$193,000 | — | 31 Mar 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,159
|
$184,000 | — | 31 Mar 2020 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0%
|
5,342
|
$159,192 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4,672
|
$139,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
3,860
|
$115,000 | — | 31 Mar 2020 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0%
|
3,777
|
$112,555 | — | 31 Mar 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0%
|
3,686
|
$110,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
3,658
|
$109,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,351
|
$100,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,014
|
$90,000 | — | 31 Mar 2020 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,700
|
$80,000 | — | 31 Mar 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,617
|
$48,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,437
|
$43,000 | — | 31 Mar 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,262
|
$38,000 | — | 31 Mar 2020 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
897
|
$27,000 | — | 31 Mar 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
557
|
$16,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
400
|
$12,000 | — | 31 Mar 2020 |
Institutional Holders of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) as of Q2 2020
As of 30 Jun 2020,
Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,776,828 shares.
The largest 10 holders included
FRAZIER MANAGEMENT LLC, FMR LLC, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., Vivo Capital, LLC, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Omega Fund Management, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
49
Q2 2020 holders
55
Holder diff
6
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.